Showing 601 - 620 results of 2,756 for search 'materials dysfunction', query time: 0.14s Refine Results
  1. 601

    Examining adherence to American Urological Association (AUA) guidelines in men’s health: Insights from the New York section AUA survey by Hunter Hernandez, John Fastenau, Ari Bernstein, Hossein Sadeghi-Nejad

    Published 2025-07-01
    “…Materials and Methods: An anonymous questionnaire was emailed to members, covering five non-oncologic men’s health guideline categories. …”
    Get full text
    Article
  2. 602
  3. 603

    Clinical characteristics of patients with different subtypes of gestational diabetes mellitus: research results by N. I. Volkova, I. Y. Davidenko, Y. S. Degtiareva, Y. A. Sorokina, V. V. Avrutskaya

    Published 2024-09-01
    “…When GDM was detected, the Matsuda index was calculated: >50th percentile in comparison with the values of pregnant women without carbohydrate metabolism disorders, the patient belonged to the group of GDM with β-cell dysfunction; <50th percentile - to the GDM group with predominant insulin resistance.RESULTS AND DISCUSSION. …”
    Get full text
    Article
  4. 604
  5. 605
  6. 606

    Efficiency of L-arginine and L-carnitine in the Complex Treatment of Patients With Acute Myocardial Infarction and Comorbid Metabolic Syndrome by Shved M., Pelo M.

    Published 2018-12-01
    “…However, modern specific treatment of endothelial dysfunction and energy supply of the myocardium is not included in the relevant protocols for the treatment of MI due to the lack of sufficient evidence. …”
    Get full text
    Article
  7. 607

    Effect of eplerenone on aldosterone and von Willebrand factor levelsin patients with myocardial infarction and chronic kidney disease by V. K. Tashchuk, O. S. Polianska, O. I. Hulaha

    Published 2022-02-01
    “…Aim: to study the levels of aldosterone and von Willebrand factor (VWF) in patients with Q-wave acute myocardial infarction (Q-AMI) and underling chronic kidney disease (CKD) using aldosterone antagonists. Materials and methods. The study group consisted of 106 patients with renal dysfunction who were hospitalized for acute Q-AMI. …”
    Get full text
    Article
  8. 608

    Comparison of Nurick Score and Modified Japanese Orthopaedic Association Score as Prognostic Indices for Surgical Outcome in Cervical Spondylotic Myelopathy Cases: A Prospective Ob... by Ramis Abdul Aziz, Sarang Gotecha, Ashish Chugh, Prashant Punia

    Published 2025-04-01
    “…Introduction: Cervical Spondylotic Myelopathy (CSM) is a leading cause of spinal cord dysfunction, particularly in elderly populations. It presents with diverse motor, sensory and autonomic symptoms. …”
    Get full text
    Article
  9. 609
  10. 610

    Association of left ventricular diastolic function with parameters of arterial stiffness and atherosclerotic plaques in the carotid basin in hypertensive patients by V. V. Syvolap, A. O. Bohun

    Published 2024-03-01
    “…Тo assess changes in the left ventricular diastolic dysfunction (LVDD) indicators depending on the elastic properties of the common carotid arteries (CCA) and the presence of atherosclerotic plaque (ASP) in patients with stage II hypertension (HTS). …”
    Get full text
    Article
  11. 611

    INFLUENCE OF ROSUVASTATIN ON VASCULAR ENDOTHELIUM FUNCTIONAL STATE AND SYSTEMIC INFLAMMATION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND DIABETES MELLITUS by I. M. Fushtey, S. L. Podsevahina, O. I. Palamarchuk, O. V. Tkachenko, I. A. Kulinich

    Published 2022-12-01
    “…Vascular endothelial dysfunction had a close correlation with markers of systemic inflammation, which was exacerbated by the presence of insulin resistance. …”
    Get full text
    Article
  12. 612
  13. 613

    Myocardial cytoprotectors demonstrate anti-apoptotic effect on vascular endotheliocytes by A. I. Inzhutova

    Published 1970-01-01
    “…Trimetazidine MR could be used as pathogenetic therapy, correcting vascular wall homeostasis in CVD patients, and also as prevention of endothelial dysfunction progression in NCD patients.…”
    Get full text
    Article
  14. 614
  15. 615
  16. 616
  17. 617

    Endothelial function and lipid peroxidation in patients with arterial hypertension and its cerebral complications by M. V. Kazak, T. S. Romanenko, M. G. Omelyanenko, A. V. Lebedeva, I. K. Tomilova, V. N. Vyatkin, A. V. Kontsevaya

    Published 2009-04-01
    “…UncomplicatedAH was characterised by compensated endothelial dysfunction, while NO-endothelium system was decompensated in stroke. …”
    Get full text
    Article
  18. 618
  19. 619
  20. 620

    EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE by T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov

    Published 2015-09-01
    “…On the basis of EchoCG data diastolic dysfunction types were determined in patients of the main group. …”
    Get full text
    Article